{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:34:24Z","timestamp":1793766864870,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijrobp.2024.11.106","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T20:52:28Z","timestamp":1734382348000},"page":"729-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Results of a Single-Arm Phase 2 Clinical Trial: Online Adaptive Stereotactic Body Radiation Therapy for Abdominal-Pelvic Oligometastases"],"prefix":"10.1016","volume":"122","author":[{"given":"Lucy A.","family":"van Werkhoven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike T.W.","family":"Milder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mischa S.","family":"Hoogeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost J.","family":"Nuyttens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.11.106_bib0001","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0002","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1002\/cncr.26067","article-title":"A survey of stereotactic body radiotherapy use in the united states","volume":"117","author":"Pan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0003","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0004","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-comet): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0005","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/1754-9485.13057","article-title":"Overall and chemotherapy-free survival following stereotactic body radiation therapy for abdominopelvic oligometastases","volume":"64","author":"Shahi","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0006","article-title":"Stereotactic body radiotherapy for lymph node oligometastases: real-world evidence from 90 consecutive patients","volume":"10","author":"Burkon","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0007","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2013.08.009","article-title":"Adaptive liver stereotactic body radiation therapy: automated daily plan reoptimization prevents dose delivery degradation caused by anatomy deformations","volume":"87","author":"Leinders","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0008","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2011.08.027","article-title":"Development of an online adaptive solution to account for inter- and intra-fractional variations","volume":"100","author":"Li","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0009","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijrobp.2014.06.046","article-title":"Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT","volume":"90","author":"Heijkoop","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0010","doi-asserted-by":"crossref","first-page":"e13479","DOI":"10.1002\/acm2.13479","article-title":"Varian ethos online adaptive radiotherapy for prostate cancer: early results of contouring accuracy, treatment plan quality, and treatment time","volume":"23","author":"Byrne","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0011","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijrobp.2022.06.078","article-title":"In silico trial of computed tomography-guided stereotactic adaptive radiation therapy (ct-star) for the treatment of abdominal oligometastases","volume":"114","author":"Schiff","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0012","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2022.05.016","article-title":"Stereotactic magnetic resonance-guided adaptive radiation therapy (smart) for abdominopelvic oligometastases","volume":"114","author":"Yang","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0013","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2022.01.038","article-title":"SMART ablation of lymphatic oligometastases in the pelvis and abdomen: clinical and dosimetry outcomes","volume":"168","author":"Regnery","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0014","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1002\/mp.12432","article-title":"Cyberknife with integrated ct-on-rails: system description and first clinical application for pancreas SBRT","volume":"44","author":"Papalazarou","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0015","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of aapm task group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.910792","article-title":"Impact of using unedited ct-based dir-propagated autocontours on online art for pancreatic SBRT","volume":"12","author":"Magallon-Baro","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0017","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2214\/AJR.09.4110","article-title":"Van den Abbeele AD. Revised recist guideline version 1.1: what oncologists want to know and what radiologists need to know","volume":"195","author":"Nishino","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10585-020-10071-x","article-title":"Systematic review of stereotactic body radiotherapy for nodal metastases","volume":"38","author":"Deodato","year":"2021","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0019","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/COC.0b013e31821f876a","article-title":"Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors","volume":"35","author":"Barney","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0020","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ijrobp.2010.05.032","article-title":"Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases","volume":"81","author":"Bignardi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/07357907.2016.1197235","article-title":"Role of stereotactic body radiation therapy with volumetric-modulated arcs and high-intensity photon beams for the treatment of abdomino-pelvic lymph-node metastases","volume":"34","author":"Franzese","year":"2016","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0022","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/COC.0b013e3182610878","article-title":"Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer","volume":"37","author":"Jereczek-Fossa","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0023","doi-asserted-by":"crossref","first-page":"37987","DOI":"10.1038\/srep37987","article-title":"Stereotactic body radiation therapy induces fast tumor control and symptom relief in patients with iliac lymph node metastasis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0024","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(97)00215-6","article-title":"Tumor volume: a basic and specific response predictor in radiotherapy","volume":"47","author":"Dubben","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0025","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-comet phase ii randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0026","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.humpath.2017.10.002","article-title":"Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important","volume":"70","author":"Shen","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0027","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clcc.2013.11.008","article-title":"Colorectal cancer survival: an analysis of patients with metastatic disease synchronous and metachronous with the primary tumor","volume":"13","author":"Kumar","year":"2014","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0029","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semradonc.2005.12.006","article-title":"Modeling growth kinetics and statistical distribution of oligometastases","volume":"16","author":"Withers","year":"2006","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"Uk consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.11.106_bib0031","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5603\/RPOR.a2022.0007","article-title":"Stereotactic radiotherapy for oligometastases in the lymph nodes","volume":"27","author":"Pasqualetti","year":"2022","journal-title":"Rep Pract Oncol Radiother"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624037131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624037131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:22:48Z","timestamp":1749201768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624037131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0360301624037131"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.11.106","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results of a Single-Arm Phase 2 Clinical Trial: Online Adaptive Stereotactic Body Radiation Therapy for Abdominal-Pelvic Oligometastases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.11.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}